IRIS
MANTUANO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.802
EU - Europa 1.074
AS - Asia 1.069
SA - Sud America 286
Continente sconosciuto - Info sul continente non disponibili 174
AF - Africa 60
OC - Oceania 10
Totale 5.475
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.654
IT - Italia 540
SG - Singapore 433
BR - Brasile 225
CN - Cina 205
HK - Hong Kong 114
RU - Federazione Russa 101
CA - Canada 93
VN - Vietnam 76
SE - Svezia 69
DE - Germania 66
FR - Francia 64
GB - Regno Unito 58
FI - Finlandia 54
BD - Bangladesh 53
IN - India 40
ES - Italia 27
ID - Indonesia 25
NL - Olanda 25
CI - Costa d'Avorio 24
JP - Giappone 22
MX - Messico 21
AR - Argentina 13
IQ - Iraq 13
PL - Polonia 12
TR - Turchia 12
ZA - Sudafrica 11
CO - Colombia 10
PK - Pakistan 10
UZ - Uzbekistan 10
AT - Austria 9
AU - Australia 9
EC - Ecuador 9
CR - Costa Rica 8
PE - Perù 8
SA - Arabia Saudita 7
UA - Ucraina 7
EG - Egitto 6
MA - Marocco 6
NI - Nicaragua 6
VE - Venezuela 6
CZ - Repubblica Ceca 5
IE - Irlanda 5
IL - Israele 5
BE - Belgio 4
BO - Bolivia 4
CL - Cile 4
DZ - Algeria 4
JO - Giordania 4
KE - Kenya 4
KG - Kirghizistan 4
LT - Lituania 4
MY - Malesia 4
PH - Filippine 4
PR - Porto Rico 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DK - Danimarca 3
EE - Estonia 3
GP - Guadalupe 3
HN - Honduras 3
KR - Corea 3
PY - Paraguay 3
UY - Uruguay 3
AL - Albania 2
BY - Bielorussia 2
CH - Svizzera 2
GR - Grecia 2
GT - Guatemala 2
KZ - Kazakistan 2
LB - Libano 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CW - ???statistics.table.value.countryCode.CW??? 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
LC - Santa Lucia 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
Totale 5.300
Salva come PNG Salva come JPEG
Città #
Ashburn 356
Singapore 253
San Jose 233
Fairfield 172
Chandler 159
Dallas 142
Hong Kong 108
Woodbridge 104
Bari 102
Council Bluffs 90
Milan 89
Cambridge 83
Beijing 74
Houston 72
Nyköping 65
Seattle 64
Wilmington 57
Los Angeles 53
New York 44
Helsinki 40
Bitetto 38
Santa Clara 31
Rome 30
Bitonto 29
Victoria 27
Lauterbourg 26
Ann Arbor 25
Abidjan 24
Ho Chi Minh City 23
São Paulo 22
Jakarta 20
Montreal 19
Brooklyn 18
Lawrence 18
Chicago 17
Roxbury 17
Hanoi 16
Munich 16
Des Moines 15
Taranto 15
Toronto 15
Columbus 14
Falkenstein 14
Grottaglie 13
Inglewood 13
Buffalo 12
Frankfurt am Main 12
Atlanta 11
Chennai 11
Turku 11
London 10
Mexico City 10
North Bergen 10
Tokyo 10
Amsterdam 9
Boardman 9
Denver 9
Naples 9
Nuremberg 9
Orem 9
Rio de Janeiro 9
Tashkent 9
San Diego 8
Belo Horizonte 7
Campinas 7
Nanjing 7
Phoenix 7
The Dalles 7
Trieste 7
Turin 7
Warsaw 7
Brescia 6
Dong Ket 6
Groningen 6
Johannesburg 6
Managua 6
Melbourne 6
Portsmouth 6
Saint Augustine 6
Shanghai 6
Baltimore 5
Boston 5
Brno 5
Carrboro 5
Jiaxing 5
Nakano 5
Newark 5
Philadelphia 5
Pittsburgh 5
Poplar 5
Redwood City 5
San José 5
Sennori 5
Tampa 5
Aldeatejada 4
Ankara 4
Baghdad 4
Bauru 4
Brussels 4
Dublin 4
Totale 3.256
Salva come PNG Salva come JPEG
Nome #
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future 382
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies 303
A long-term treatment with taurine prevents cardiac dysfunction in mdx mice 264
Contractile efficiency of dystrophic mdx mouse muscle: In vivo and ex vivo assessment of adaptation to exercise of functional end points 254
Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of Duchenne muscular dystrophy: a comparison with the gold standard, α-methyl prednisolone. 252
Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy 244
Dasatinib/HP-β-CD inclusion complex based aqueous formulation as a promising tool for the treatment of paediatric neuromuscular disorders 223
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy. 204
BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: preclinical evaluation in a murine model of hind limb unloading 171
Ergogenic effect of bcaas and l-alanine supplementation: Proof-of-concept study in a murine model of physiological exercise 170
Alteration of stim1/orai1-mediated soce in skeletal muscle: Impact in genetic muscle diseases and beyond 159
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity 156
Synthetic lethality to overcome cancer drug resistance 154
"The Social Network" and Muscular Dystrophies: The Lesson Learnt about the Niche Environment as a Target for Therapeutic Strategies 152
Ultrasonography validation for early alteration of diaphragm echodensity and function in the mdx mouse model of Duchenne muscular dystrophy 149
Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds 147
LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model 142
β‐Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation 137
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 136
Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia 126
Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients 126
Branched-chain amino acids and L-alanine supplementation ameliorate calcium dyshomeostasis in sarcopenia: New insights for nutritional interventions 118
Determination of qPCR reference genes suitable for normalizing gene expression in a novel model of Duchenne muscular dystrophy, the D2-mdx mouse 114
Effect of exercise on telomere length and telomere proteins expression in mdx mice 108
Synergistic antiproliferative and antiangiogenic effects of EGFR and mTOR inhibitors 103
null 93
Preclinical Ultrasonography in Rodent Models of Neuromuscular Disorders: The State of the Art for Diagnostic and Therapeutic Applications 91
Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase. 89
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future 88
On the use of D2.B10-Dmdmdx/J (D2.mdx) Versus C57BL/10ScSn-Dmdmdx/J (mdx) Mouse Models for Preclinical Studies on Duchenne Muscular Dystrophy: A Cautionary Note from Members of the TREAT-NMD Advisory Committee on Therapeutics 74
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 72
Clinical course and management challenges in Lafora disease: a narrative analysis in an Apulian cohort 57
Data on protein abundance alteration induced by chronic exercise in mdx mice model of Duchenne muscular dystrophy and potential modulation by apocynin and taurine 56
PRE-CLINICAL ASSESSMENT OF THE ROLE OF THE COMPLEMENT SYSTEM IN TRIGGERING FIBROSIS IN DUCHENNE MUSCULAR DYSTROPHY: TOWARDS NOVEL THERAPEUTIC TARGETS 52
A two-site collaborative study of electrical impedance myography for evaluation of disease progression in murine Duchenne muscular dystrophy models 42
Natural history study of the D2-mdx mouse for Duchenne muscular dystrophy: a comparison across two independent study sites 38
Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model. 34
Validation of exploratory biomarkers of sarcopenia in community-dwelling older adults: insights from the IN-TEMPO clinical trial. 32
Branched-chain amino acid supplementation in a mouse model of ageing: Effects on age-related kidney fibrosis 30
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 30
Diaphragm‐specific effects of L‐citrulline in mdx mice highlight its potential as adjuvant of standard therapy in Duchenne muscular dystrophy 29
Electrical impedance myography as a tool for monitoring disease progression in mouse models of Duchenne Muscular Dystrophy: a longitudinal, multisite study 27
254PActivation of complement cascade may trigger inflammation and fibrosis in Duchenne muscular dystrophy: a preclinical investigation on two murine models 27
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 15
LKB1 Dysregulation in Duchenne Muscular Dystrophy Models: Disease Specificity and Epigenetic Control by HDAC Inhibitors 5
Totale 5.475
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.712
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022148 0 0 0 1 2 15 18 0 16 16 31 49
2022/2023356 26 52 26 38 29 43 2 41 56 5 21 17
2023/2024179 8 34 8 14 15 34 2 14 4 16 10 20
2024/2025882 32 6 26 28 31 101 157 109 55 54 112 171
2025/20262.285 338 78 256 173 248 102 218 80 296 226 105 165
2026/2027787 133 109 218 327 0 0 0 0 0 0 0 0
Totale 5.475